ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Delivery

Microneedle patch encourages hair to regrow

Mice treated with the drug-delivery device regrew hair in less than 1 week

by Bethany Halford
April 12, 2019 | APPEARED IN VOLUME 97, ISSUE 15

 

09715-scicon10-needles.jpg
Credit: ACS Nano
A scanning electromicrograph of the microneedle patch. Each needle is 300 μm in diameter at its base and 600 μm tall.

A patch covered in tiny microneedles can regrow hair in mice, scientists report. The patch could lead to treatment for hair loss in people, say its creators, a team led by Zhen Gu of the University of California, Los Angeles, and Liang Zhang of the Chinese Academy of Sciences. Gu, Zhang, and coworkers created the microneedles using a hydrogel containing keratin, the protein that makes up hair. They reasoned that this material would be both biocompatible and biodegradable. They loaded the microneedles with UK 5099, a small molecule that’s known to promote hair growth, and exosomes from a certain type of stem cell that can activate hair follicles. The microneedles are almost invisible once they’ve been applied to the skin and their hyaluronic acid backing has been removed. In tests with shaved mice, the microneedle system regrew hair in 6 days with just two treatments (ACS Nano 2019, DOI: 10.1021/acsnano.8b09573). Mice that got topical treatments of UK 5099 and exosome injections regrew hair more slowly. Untreated mice didn’t regrow hair at all. Gu thinks the microneedle patch brings its therapeutic cargo directly into the hair follicle stem cells’ niche, making it possible to steadily deliver low doses of the therapy where it’s most useful.

X

Article:

This article has been sent to the following recipient:

Comments
Andrew Miller (June 29, 2019 12:51 AM)
Where,how, and when will this be available? What's the delay in getting it to market?

Leave A Comment

*Required to comment